Health
Immunomodulatory drugs improve the success rate of cancer therapies – News-Medical.Net
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such…
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.
Researchers at the Technical University of Munich (TUM) have now further decoded the mode of action in this class of medications. At the same time, they identified new innovative targeted cancer therapies.
The drug thalidomide was sold as a sedative under the trade name Contergan in the 1950s and 1960s. At the time,…
Continue Reading
